First CDC signed off on a COVID-19 vaccine for adults, then teens. Now US children ages 5 to 11 are officially eligible for shots. Here’s the science on why each group needs to be considered separately.
L’expertise universitaire, l’exigence journalistique
Articles sur Vaccine research
Ensemble des articles
It sounds too good to be true, a vaccine that can protect against future virus variants. But governments around the world are keen to learn more.
As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
The Russian cyberthreat, now targeting coronavirus vaccine research, goes back over three decades, extends into the country’s educational systems and criminal worlds, and shows no signs of letting up.
To find a SARS-CoV-2 vaccine, scientists need to work hands-on with the highly infectious coronavirus. It happens in a super secure lab designed to keep them safe and prevent any escapes.
This fifth weekly column by our team of international health editors highlights more of the recently published articles from The Conversation’s global network.
Researchers around the world are working hard on developing a vaccine – but the process may still take 12-18 months. Here’s why.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
Speaking on the ABC program Insiders, One Nation leader Pauline Hanson suggested there are tests available to see if children will have an adverse reaction to vaccinations. We asked three experts.
Researchers are learning how HIV hides from the immune system to develop a new generation of vaccines for seemingly unrelated diseases, like the flu.
Prospective parents, aware of how devastating whooping cough can be, want to leave no stone unturned to protect their baby. But is No Vax, No Visit supported by the best evidence?
Big pharma is finally starting to pay attention to the developing world. Here’s why.
Researchers from Vanderbilt University have discovered a new method of vaccination where tiny gold particles target immune…
Les contributeurs les plus fréquents
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Professor and Director for the National Centre for Immunisation Research and Surveillance of Vaccine, University of Sydney
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Professor, Biomedicine Discovery Institute, Monash University
-
Senior lecturer in health economics, London School of Hygiene & Tropical Medicine
-
Associate Professor, University of Oxford
-
Senior Research Officer, Telethon Kids Institute
-
Research Fellow, National Centre for Immunisation Research & Surveillance, and School of Public Health, University of Sydney
-
Professor of Paediatric Infection and Immunity, University of Oxford
-
Emeritus Distinguished Professor of Defense Analysis, Naval Postgraduate School
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Vaccine Knowledge Project Manager, University of Oxford
-
Humanitarian Affairs Advisor, L’Université d’Ottawa/University of Ottawa
-
Research Assistant Professor of Epidemiology, University of Michigan
-
Assistant Professor of Veterinary and Biomedical Sciences, Penn State
